2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 1.804 | 235 | 0 | 0 | 258 | 5.536 | 0 | 0 | 0 | 1.577 |
Total Income - EUR | 1.804 | 235 | 0 | 0 | 258 | 5.536 | 0 | 0 | 0 | 1.577 |
Total Expenses - EUR | 3.381 | 3.328 | 0 | 66 | 1.073 | 1.965 | 2 | 15 | 0 | 319 |
Gross Profit/Loss - EUR | -1.577 | -3.093 | 0 | -66 | -815 | 3.570 | -2 | -15 | 0 | 1.258 |
Net Profit/Loss - EUR | -1.631 | -3.100 | 0 | -66 | -818 | 3.405 | -2 | -15 | 0 | 1.057 |
Employees | 2 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Andimed Center Ltd S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 693 | 602 | 607 | 596 | 860 | 4.016 | 1 | 17 | 17 | 1.486 |
Inventories | 502 | 527 | 522 | 513 | 503 | 3 | 0 | 0 | 0 | -17 |
Receivables | 89 | 44 | 44 | 43 | 42 | 0 | 0 | 0 | 0 | 0 |
Cash | 102 | 31 | 41 | 40 | 314 | 4.014 | 1 | 17 | 17 | 1.503 |
Shareholders Funds | -1.587 | -4.699 | -4.652 | -4.639 | -5.372 | -1.863 | -1.831 | -1.805 | -1.811 | -749 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 2.279 | 5.301 | 5.258 | 5.235 | 6.232 | 5.879 | 1.832 | 1.822 | 1.827 | 2.235 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year | 8690 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.